Clinical practice guidelines from the AABB: Red blood cell transfusion thresholds and storage

JAMA - Journal of the American Medical Association

Volumn 316, Issue 19, 2016, Pages 2025-2035

  Carson, Jeffrey L ^a   Guyatt, Gordon ^b   Heddle, Nancy M ^b   Grossman, Brenda J ^c   Cohn, Claudia S ^d   Fung, Mark K ^e   Gernsheimer, Terry ^f   Holcomb, John B ^g   Kaplan, Lewis J ^h   Katz, Louis M ^i,j   Peterson, Nikki ^k   Ramsey, Glenn ^l   Rao, Sunil V ^m   Roback, John D ⁿ   Shander, Aryeh ^o   Tobian, Aaron A R ^p  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ America's Blood Centers   (United States)

^j UNIVERSITY OF IOWA   (United States)

^k Northwestern University ^*  (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ACUTE CORONARY SYNDROME; ADULT; ANEMIA; BLEEDING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CRITICALLY ILL PATIENT; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HEART SURGERY; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; LUNG EDEMA; ORTHOPEDIC SURGERY; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTOPENIA; THROMBOEMBOLISM; BLOOD BANK; CRITICAL ILLNESS; DECISION MAKING; PATIENT PREFERENCE; PROCEDURES; REFERENCE VALUE; STANDARDS; TIME FACTOR;

BLOOD BANKS; CRITICAL ILLNESS; DECISION MAKING; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; PATIENT PREFERENCE; REFERENCE VALUES; TIME FACTORS;

EID: 85006093247     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.9185     Document Type: Review

References (112)

1. World Health Organization. Blood safety and availability. http://www.who.int/mediacentre/factsheets/fs279/en/. Accessed January 25, 2016.
2. Whitaker BI, Rajbhandary S, Harris, A. The 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey Report. Bethesda, MD: AABB; 2015.
3. Rao SV, Chiswell K, Sun JL, et al. International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol. 2008;101(1):25-29.
4. Rogers MA, Blumberg N, Saint S, Langa KM, Nallamothu BK. Hospital variation in transfusion and infection after cardiac surgery: A cohort study. BMC Med. 2009;7:37.
5. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304(14): 1568-1575.
6. Frank SM, SavageWJ, Rothschild JA, et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology. 2012;117(1): 99-106.
7. Kwok CS, SherwoodMW,Watson SM, et al. Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: A systematic review and meta-analysis. JACC Cardiovasc Interv. 2015;8(3):436-446.
8. Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Red blood cell transfusion practice in elective orthopedic surgery: A multicenter cohort study. Transfusion. 2010;50 (10):2117-2124.
9. Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996;84(3):732-747.
10. Napolitano LM, Kurek S, Luchette FA, et al; American College of Critical Care Medicine of the Society of Critical Care Medicine; Eastern Association for the Surgery of Trauma Practice ManagementWorkgroup. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124-3157.
11. Federowicz I, Barrett BB, Andersen JW, Urashima M, Popovsky MA, Anderson KC. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion. 1996;36(1):21-28.
12. Popovsky MA, Audet AM, Andrzejewski C Jr. Transfusion-associated circulatory overload in orthopedic surgery patients: A multi-institutional study. Immunohematology. 1996;12(2):87-89.
13. Clifford L, Jia Q, Yadav H, et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology. 2015;122(1):21-28.
14. DeBaun MR, Gordon M, McKinstry RC, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371 (8):699-710.
15. Sanguis Study Group. Use of blood products for elective surgery in 43 European hospitals. Transfus Med. 1994;4(4):251-268.
16. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 2010;50(7):1495-1504.
17. Stramer SL, Notari EP, Krysztof DE, Dodd RY. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Transfusion. 2013;53(10, pt 2):2449-2458.
18. US Food and Drug Administration. Transfusion/donation fatalities: notification process for transfusion related fatalities and donation related deaths. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/. Accessed August 1, 2016.
19. Tinmouth A, Fergusson D, Yee IC, Hébert PC, ABLE Investigators; Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46(11):2014-2027.
20. Roback JD, Neuman RB, Quyyumi A, Sutliff R. Insufficient nitric oxide bioavailability: A hypothesis to explain adverse effects of red blood cell transfusion. Transfusion. 2011;51(4):859-866.
21. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood. 2011;118(25):6675-6682.
22. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12):1229-1239.
23. Manlhiot C, McCrindle BW, Menjak IB, et al. Longer blood storage is associated with suboptimal outcomes in high-risk pediatric cardiac surgery. Ann Thorac Surg. 2012;93(5):1563-1569.
24. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion. 1999;39(7):701-710.
25. van deWatering L, Lorinser J, Versteegh M, Westendord R, Brand A. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion. 2006;46(10):1712-1718.
26. Vamvakas EC, Carven JH. Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion. 2000;40(1):101-109.
27. Edgren G, Kamper-Jørgensen M, Eloranta S, et al. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010; 50(6):1185-1195.
28. Carson JL, Grossman BJ, Kleinman S, et al; Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: A clinical practice guideline from the AABB. Ann Intern Med. 2012;157 (1):49-58.
29. Strauss RG, Burmeister LF, Johnson K, et al. AS-1 red cells for neonatal transfusions: A randomized trial assessing donor exposure and safety. Transfusion. 1996;36(10):873-878.
30. Schulman CI, Nathe K, Brown M, Cohn SM. Impact of age of transfused blood in the trauma patient. J Trauma. 2002;52(6):1224-1225.
31. Fernandes da Cunha DH, Nunes Dos Santos AM, Kopelman BI, et al. Transfusions of CPDA-1 red blood cells stored for up to 28 days decrease donor exposures in very low-birth-weight premature infants. Transfus Med. 2005;15(6):467-473.
32. Hébert PC, Chin-Yee I, Fergusson D, et al. A pilot trial evaluating the clinical effects of prolonged storage of red cells. Anesth Analg. 2005;100(5): 1433-1438.
33. Bennett-Guerrero E, Stafford-Smith M, Waweru PM, et al. A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients. Transfusion. 2009;49(7): 1375-1383.
34. Aubron C, Syres G, Nichol A, et al. A pilot feasibility trial of allocation of freshest available red blood cells versus standard care in critically ill patients. Transfusion. 2012;52(6):1196-1202.
35. Fergusson DA, Hébert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: The ARIPI randomized trial. JAMA. 2012; 308(14):1443-1451.
36. Heddle NM, Cook RJ, Arnold DM, et al. The effect of blood storage duration on in-hospital mortality: A randomized controlled pilot feasibility trial. Transfusion. 2012;52(6):1203-1212.
37. Kor DJ, Kashyap R,Weiskopf RB, et al. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: A randomized clinical trial. Am J Respir Crit Care Med. 2012;185(8): 842-850.
38. Dhabangi A,Mworozi E, Lubega IR, Cserti-Gazdewich CM, Maganda A, Dzik WH. The effect of blood storage age on treatment of lactic acidosis by transfusion in children with severe malarial anaemia: A pilot, randomized, controlled trial. Malar J. 2013;12:55.
39. DhabangiA, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: The TOTAL randomized clinical trial. JAMA. 2015;314 (23):2514-2523.
40. Lacroix J, Hébert PC, Fergusson DA, et al; ABLE Investigators; Canadian Critical Care Trials Group. Age of transfused blood in critically ill adults. N Engl J Med. 2015;372(15):1410-1418.
41. Steiner ME, Ness PM, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015;372(15):1419-1429.
42. AABB. AABB policy on conflicts of interest and confidentiality. http://www.aabb.org/membership/governance/committees/Pages/AABB-Conflicts-of-Interest-Disclosure-Form.aspx. Accessed February 15, 2016.
43. Carson JL, Stanworth SJ, Roubinian NR, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;(10):CD002042.
44. Alexander PE, Barty R, Fei Y, et al. Transfusion of fresher vs older red blood cells in hospitalized patients: A systematic review and meta-analysis. Blood. 2016;127(4):400-410.
45. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet. 2001; 357(9254):455-462.
46. Middelburg RA, van deWatering LM, van der Bom JG. Blood transfusions: good or bad? confounding by indication, an underestimated problem in clinical transfusion research. Transfusion. 2010;50(6):1181-1183.
47. Cochrane Colllaboration. Cochrane Handbook for Systematic Reviews of Interventions: Version 5.1.0. Hoboken, NJ: John Wiley & Sons; 2011.
48. Cochrane Bias Methods Group. Assessing risk of bias in included studies. http://methods .cochrane.org/bias/assessing-risk-bias-included-studies. Accessed July 15, 2015.
49. Sun X, Briel M,Walter SD, Guyatt GH. Is a subgroup effect believable? updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:c117.
50. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
51. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
52. Atkins D, Best D, Briss PA, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328 (7454):1490.
53. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg. 1986;73 (10):783-785.
54. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070-1077.
55. Bush RL, PevecWC, Holcroft JWA. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg. 1997;174(2):143-148.
56. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165(6):964-971.e1.
57. Carson JL, Sieber F, Cook DR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet. 2015;385 (9974):1183-1189.
58. Carson JL, Terrin ML, Barton FB, et al. A pilot randomized trial comparing symptomatic vs hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion. 1998;38(6):522-529.
59. Carson JL, Terrin ML,Magaziner J, et al; FOCUS Investigators. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion. 2006;46(12):2192-2206.
60. Carson JL, Terrin ML, Noveck H, et al; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453-2462.
61. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acutemyocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108(8):1108-1111.
62. Fan Y-X, Liu F-F, Jia M, et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: A preliminary study. Arch Gerontol Geriatr. 2014;59(1):181-185.
63. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009;49(2):227-234.
64. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: The TRIFE randomized controlled trial. Acta Orthop. 2015;86 (3):363-372.
65. Gregersen M, Borris LC, Damsgaard EM. Blood transfusion and overall quality of life after hip fracture in frail elderly patients-the transfusion requirements in frail elderly randomized controlled trial. J AmMed Dir Assoc. 2015;16(9):762-766.
66. Gregersen M, Damsgaard EM, Borris LC. Blood Transfusion and Risk of Infection in Frail Elderly after hip fracture surgery: The TRIFE randomized controlled trial. Eur J Orthop Surg Traumatol. 2015; 25(6):1031-1038.
67. GroverM, Talwalkar S, Casbard A, et al. Silent myocardial ischaemia and haemoglobin concentration: A randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang. 2006;90(2):105-112.
68. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA. 2010; 304(14):1559-1567.
69. Hébert PC,Wells G, Blajchman MA, et al; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340(6):409-417.
70. Hébert PC,Wells G, Marshall J, et al; Canadian Critical Care Trials Group. Transfusion requirements in critical care: A pilot study [published correction appears in JAMA. 1995;274(12):944]. JAMA. 1995; 273(18):1439-1444.
71. Holst LB, Haase N,Wetterslev J, et al; TRISS Trial Group; Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371 (15):1381-1391.
72. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): A pragmatic, open-label, cluster randomised feasibility trial. Lancet. 2015;386(9989):137-144.
73. Johnson RG, Thurer RL, Kruskall MS, et al. Comparison of two transfusion strategies after elective operations formyocardial revascularization. J Thorac Cardiovasc Surg. 1992; 104(2):307-314.
74. Lacroix J, Hébert PC, Hutchison JS, et al; TRIPICU Investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609-1619.
75. Lotke PA, Barth P, Garino JP, Cook EF. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. J Arthroplasty. 1999;14(6):647-650.
76. Murphy GJ, Pike K, Rogers CA, et al; TITRe2 Investigators. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997-1008.
77. Nielsen K, Johansson PI, Dahl B, et al. Perioperative transfusion threshold and ambulation after hip revision surgery-a randomized trial. BMC Anesthesiol. 2014;14:89.
78. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury. 2013;44(12):1916-1918.
79. de Almeida JP, Vincent JL, Galas FR, et al. Transfusion requirements in surgical oncology patients: A prospective, randomized controlled trial. Anesthesiology. 2015;122(1):29-38.
80. Prick BW, Jansen AJ, Steegers EA, et al. Transfusion policy after severe postpartum haemorrhage: A randomised non-inferiority trial. BJOG. 2014;121(8):1005-1014.
81. Shehata N, Burns LA, Nathan H, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion. 2012;52(1):91-99.
82. So-Osman C, Nelissen R, Brand R, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: A post-hoc analysis of a randomised study. Blood Transfus. 2013;11(2):289-295.
83. Fisher MR, Topley E. The illness of trauma. Br J Clin Pract. 1956;10(11):770-776.
84. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368 (1):11-21.
85. Walsh TS, Boyd JA,Watson D, et al; RELIEVE Investigators. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: A randomized pilot trial. Crit Care Med. 2013;41(10):2354-2363.
86. Webert KE, Cook RJ, Couban S, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 2008;48(1):81-91.
87. DeZern AE, Williams K, Zahurak M, et al. Red blood cell transfusion triggers in acute leukemia: A randomized pilot study. Transfusion. 2016;56(7): 1750-1757.
88. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis. JAMA. 2014;311(13):1317-1326.
89. Clinical Trials website. Transfusion Requirements in Cardiac Surgery III (TRICS-III). https://clinicaltrials.gov/ct2/show/NCT02042898. Accessed August 1, 2016.
90. Anderson HT, Kessinger JM, McFarlandWJ Jr, Laks H, Geha AS. Response of the hypertrophied heart to acute anemia and coronary stenosis. Surgery. 1978;84(1):8-15.
91. Hagl S, HeimischW, Meisner H, Erben R, Baum M, Mendler N. The effect of hemodilution on regionalmyocardial function in the presence of coronary stenosis. Basic Res Cardiol. 1977;72(4): 344-364.
92. Wilkerson DK, Rosen AL, Sehgal LR, Gould SA, Sehgal HL, Moss GS. Limits of cardiac compensation in anemic baboons. Surgery. 1988;103(6):665-670.
93. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034): 1055-1060.
94. Valles J, Santos MT, Aznar J, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 1991;78(1):154-162.
95. Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion. 1988;28(5):406-411.
96. Blajchman MA, Bordin JO, Bardossy L, Heddle NM. The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol. 1994;86(2):347-350.
97. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion. 2001;41(8):977-983.
98. DeZern AE, Williams K, Zahurak M, et al. Red blood cell transfusion triggers in acute leukemia: A randomized pilot study. Transfusion. 2016;56(7): 1750-1757.
99. Whitaker BI, Hinkins S. The 2011 national blood collection and utilization survey report. http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf. Accessed July 19, 2016.
100. Hamm CW, Bassand JP, Agewall S, et al; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999-3054.
101. Ferraris VA, Brown JR, Despotis GJ, et al; Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion; International Consortium for Evidence Based Perfusion. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944-982.
102. Kidney Disease: Improving Global Outcomes (KDIGO) AnemiaWork Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279-335.
103. National Blood Authority Australia. Patient blood management guidelines. https://www.blood.gov.au/pbm-guidelines. Accessed June 14, 2014.
104. Retter A,Wyncoll D, Pearse R, et al; British Committee for Standards in Haematology. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160(4):445-464.
105. Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Treatment of anemia in patients with heart disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013;159(11): 770-779.
106. Rogers GM, Gela D, Cleeland C, et al. NCCN Guidelines Version 2.2014 Cancer-and Chemotherapy-Induced Anemia. NCCN Clinical Practice Guidelines in Oncology. FortWashington, PA: National Comprehensive Cancer Network; 2013.
107. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122(2):241-275.
108. National Blood Authority Australia. Guidelines for the administration of blood products: 2011. https://www.blood.gov.au/pbm-guidelines. Accessed August 19, 2016.
109. Docherty AB, O'Donnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis [published online March 29, 2016]. BMJ. doi:10.1136/bmj.i1351
110. ClinicalTrials.gov website. Age of Blood in Children in Pediatric Intensive Care Units (ABC PICU). https://clinicaltrials.gov/ct2/show/NCT01977547. Accessed January 30, 2016.
111. ClinicalTrials.gov website. Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care-A Randomised Controlled Trial (TRANSFUSE). https://clinicaltrials.gov/ct2/show/NCT01638416?term=age+of+blood&rank=3. Accessed January 30, 2016.
112. Kaukonen KM, BaileyM, Ady B, et al. A randomised controlled trial of Standard Transfusion Versus Fresher Red Blood Cell Use in Intensive Care (TRANSFUSE): protocol and statistical analysis plan. Crit Care Resusc. 2014;16 (4):255-261.